Nemera (PRIVATE.NEMERA)

Overall impact
A (84)

Commentary

Nemera is a leader for overall positive impact. With an 'A' rating of 84.4 for overall impact (97th percentile compared to all companies), Nemera ranks 8th out of 155 industry peers, behind Sysmex, Cochlear, SpiroX and 4 others, and ahead of Hologic, American Shared Hospital Services, Accuray and 144 others. On top material causes for Nemera's industry (Healthcare Equipment), Nemera performs well in Free, Secure Flow of Information (95.1 score), Child and Maternal Health (95.4), Sanitation Access (95.3) and 8 other causes where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (37.7 score).
Impact
Cause PRIVATE.NEMERA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2003
Employees
1,145
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Auvergne Rhône Alpes, France
Share classes
PRIVATE.NEMERA
More info
Description
Manufacturer of plastic drug administration systems intended to build patient-centric and sustainable drug delivery devices that bring maximum value to customers, patients, and society. The company offers the production, designing, and selling of a broad range of complex medical devices and drug delivery devices, including inhalers, insulin pens, and pumps for the pharmaceutical, biotech, and generics industries, thereby helping maximize treatment efficacy.
Material causes
Ethos considers the following causes material for Nemera, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.